Are porcine and human TSH receptor antibody measurements comparable?

Clinical Laboratory

Volumn 54, Issue 1-2, 2008, Pages 1-8

  Zöphel, Klaus ^a   von Landenberg, Philipp ^b   Roggenbuck, Dirk ^c   Wunderlich, Gerd ^a   Kotzerke, Joerg ^a   Lackner, Karl J ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c GA GENERIC ASSAYS GMBH   (Germany)

Author keywords

Human TSH receptor; Porcine TSH receptor; Second generation TRAb assay; TRAb; TSH receptor antibody

Indexed keywords

HUMAN THYROTROPIN RECEPTOR; PORCINE THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GERMANY; GRAVES DISEASE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; SWINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; FEMALE; GRAVES DISEASE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, THYROTROPIN; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SPECIES SPECIFICITY; SWINE; THYROID FUNCTION TESTS;

SUS;

EID: 43249095276     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Shewring G, Rees Smith B. An improved radioreceptor assay for TSH receptor antibodies. C]in Endocrinol (Oxf) 1982; 17: 409-414
2. Kakinuma A, Morimoto I, Kuroda T et al. Comparison of recombinant human thyrotropin receptors versus porcine receptors in the thyrotropin binding inhibition assay for thyrotropin receptor autoantibodies. Thyroid 1999; 95: 849-855
3. Costagliola S, Morgenthaler NG, Hoermann R et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999; 84: 90-97
4. 125I-labelled TSH receptor. J Clin Endocrinol Metab 1999; 84: 3797-3802
5. Bolton J, Sanders J, Oda Y et al. Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. Clin Chem 1999; 45: 2285-2287
6. Zöphel K, Wunderlich G, Koch R, Franke WG. Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease. Nuklearmedizin 2000; 39: 113-120
7. Schott M, Feldkamp J, Bathan C, Fritzen R, Scheerbaum WA, Seissler J. Detecting TSH-Receptor Antibodies with the Recombinant TBII Assay: Technical and Clinical Evaluation. Horm Metab Res 2000; 32: 429-435
8. Meller J, Schreivogel I, Bergmann A, Morgenthaler N, Hüfner M, Becker W. Clinical implications of a new TSH receptor antibody assay (DYNOtest TRAKhuman) in autoimmune thyroid diseases. Nuklearmedizin 2000; 39: 5-9
9. Meller J, Jauho A, Hüfner M, Gratz S, Becker W. Disseminated Thyroid Autonomy or Graves' Disease: Reevaluation by a Second Generation TSH Receptor Antibody Assay. Thyroid 2000; 10: 1073-1079
10. Massart C, Orgiazzi J, Maugendre D. Clinical validity of a new commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs. Clin Chim Acta 2001; 304: 39-47
11. Bülow Pedersen I, Knudsen N, Perrild H, Ovesen L, Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol 2001; 55: 381-390
12. Giovanella L, Ceriani L, Garancini S. Evaluation of the 2nd generation radio-receptional assay for anti-TSH-receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO). Q J Nucl Med 2001; 45: 115-119
13. Kamijo K. TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a compare-son of two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioimmunoassay using human recombinant TSH-receptor. Endocr J 2003; 50: 113-116
14. Hirooka Y, Li C, Takagi J et al. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease. Int J Clin Pharm Res 2004; 24: 111-116
15. Okamoto Y, Tanigawa SI, Ishikawa K, Hamada N. TSH recaptor antibody measurements and prediction of remission in Graves' disease patients treated with minimum maintenance doses of antithyroid drugs. Endocr J 2006; 53: 467-472
16. Farid NR, Szkudlinski MW. Minireview: structural and functional evolution of the thyrotropin receptor. Endocrinology 2004; 145: 4048-4057
17. Ekins R, Edwards P. On the meaning of sensitivity. Clin Chem 1997; 43: 1824-1831
18. Bland M. An introduction to medical statistics. 3rd edition Oxford Oxford Univiersity Press 2000
19. Zimmermann-Belsing T, Nygaard B, Rasmussen AK, Feldt-Rasmussen U. Use of the second generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease. Eur J Endocrinol 2002; 146: 173-177
20. Jensen E, Petersen PH, Blaabjerg O, Hansen PS, Hegedüs L. Improved sensitivity of a thyrotropin receptor antibody assay. Clin Chem 2005; 51: 2186-2187
21. Maugendre D, Massart C. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. Clin Endocrinol (Oxf) 2001; 54: 89-96
22. Zöphel K, Wunderlich G, Kopprasch C, Koch R, Franke WG, Kotzerke J. Predictive value of thyrotropin receptor antibodies using the second generation TRAb human assay after radio-iodine treatment in Graves' disease. Nuklearmedizin 2003; 42: 63-70
23. Zöphel K, Wunderlich G. Predictive value of TSH receptor antibody measurement in Graves' disease is independent on the TSH receptor (human or porcine) but depends on the generation of the assay used. Endocr J 2006; 53: 869-870 (Letter to the Editor)
24. Kashiwai T, Hidaka Y, Takano T et al. Practical treatment with minimum maintenance dose of anti-thyroid drugs for prediction of remission in Graves' disease. Endocr J 2003; 50: 45-49
25. Cardia MS, Lima N, Knobel M, Medeiros-Neto G. Evaluation of a coated-tube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorders. Thyroid 2004; 14: 295-300
26. Ishihara T, Saiki Y, Ikekubo K et al. Evaluation of a 1 step TRAb assay for the detection of high-affinity components to hTSHR: Evidences indicating superiority of the assay in the lower TRAb range. Endocr J 2006; 53: 147-155
27. Izumi Y, Takeoka K, Amino N. Usefulness of the 2nd generation assay for Anti-TSH Recepetor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroidditis after antithyroid drug treatment for Graves' disease. Endocr J 2005; 52: 493-497
28. Wood WG, Hanke R. Comparability of Method Results and Performance in a National External Quality Assessment Scheme between 1993 and 2003 using Thyroid Associated Antibodies as Examples. Clin Lab 2004; 50: 209-221
29. Wood WG. Sample Commutability in External Quality Assessment Surveys (EQAS) for Thyroid-Related Antibodies - State of the Art. Clin Lab 2007; 53: 217-222